Inovio Pharmaceuticals Inc. closed 86.44% short of its 52-week high of $14.75, which the company achieved on April 1st.

Shares of Inovio Pharmaceuticals Inc. INO slid 4.78% to $1.99 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.20% ...

1）按可比计算，从上期减去1.5万吨 Cobar（2023年6月售出）产量，自有铜产量为95.16万吨，比2023年少4.35万吨（4%）。这反映了Antapaccay和Collahuasi的计划产量下降，Antapaccay的岩土工程相关延误以及 KCC 的品位较低和计划外的工厂停工进一步影响了产量。

Cardinal Health (NYSE:CAH) reported its second-quarter earnings for fiscal year 2024, surpassing analyst expectations with an ...

One of the best dividend stocks out there is also one of the safest for creating a perfect passive income stream. The post Invest $18,000 in This Dividend Stock for $9,332.20 in Passive Income ...

Microsoft's recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting ...

Detailed price information for Inovalis REIT (INO-UN-T) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TORONTO, January 09, 2025--Inovalis Real Estate Investment Trust (the "REIT") (TSX: INO.UN) today announced the signing of an exchange contract for the sale of 87.5% of the Arcueil property to two ...

INO-6160 is under clinical development by Inovio Pharmaceuticals and currently in Phase I for Human Immunodeficiency Virus (HIV) Infections (AIDS). According to GlobalData, Phase I drugs for Human ...